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B cells play a central role in the pathogenesis of many
autoimmune diseases. Therefore, understanding the
mechanisms that regulate B-cell tolerance in humans is
important for the development of new therapeutic strate-
gies. Patients with monogenic diseases provide rare oppor-
tunities to study the impact of specific gene mutations on
the regulation of human B cell tolerance. By this, we could
show that alterations in B-cell receptor and Toll-like
receptor (TLR) signaling pathways result in defective cen-
tral B-cell tolerance.
To further dissect the signaling pathways involved in the
establishment of central B-cell tolerance in humans, we
tested by ELISA and immunofluorescence the reactivity of
recombinant antibodies cloned from single transitional
B cells from individuals carrying CD19 mutations. CD19 is
a co-receptor expressed on B cells and is involved in the
amplification of B-cell responses.
We found that individuals carrying CD19 mutations dis-
played defective central B-cell tolerance checkpoints. In
addition, CD19-deficient transitional B cells were enriched
in anti-nuclear clones, a feature previously observed in
IRAK4- and MYD88-deficient patients in which TLR7/9
sensing nucleic acids cannot signal. Therefore, we investi-
gated the functions of these TLRs in B cells in the absence
of CD19 expression. CD19-deficient human B cells dis-
played defective up-regulation of activation markers after
TLR7/9 triggering and failed to induce BTK, AKT but
not p38 MAPK or I-Ba phosphorylation after TLR7/9
stimulation. Additionally, inhibitors blocking BTK, AKT
and PI3K function impaired CD19-dependent TLR7/9
responses in healthy donor’s B cells. Finally, we demon-
strated that individuals carrying BTK mutations display
similar defects in TLR7/9-induced B-cell activation and
central B-cell tolerance.
Hence, we identified a previously unsuspected role for
CD19 molecules in regulating TLR7/9 functions in human
B cells and central B-cell tolerance to nuclear antigens.
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